Answers are grounded in this paper and cite their sources.
Dysarthria is one of the common symptoms among patients with Parkinson’s disease. It is mainly characterized by reduced volume, monotonous pitch, weakened stress, unstable speech rate, inaccurate pronunciation, and impaired rhythm, severely affecting the patients’ quality of life and mental health. Numerous studies have indicated that the efficacy of pharmacotherapy and surgical therapy on articulation function remains inconsistent and controversial. In recent years, relevant studies have revealed that non-invasive brain stimulation can improve phonation in patients with Parkinson’s disease, regulate the excitability of the stimulated brain regions and the functional connectivity between these regions and the cortices associated with speech control. However, existing research on non-invasive brain stimulation for the treatment of dysarthria in Parkinson’s disease remains limited, characterized by inconsistent stimulation parameters, small sample sizes, and insufficient investigation into the underlying mechanisms. This narrative review summarizes the common techniques in non-invasive brain stimulation, including the research progress, potential mechanisms, and safety of repetitive transcranial magnetic stimulation and transcranial direct current stimulation in the treatment of speech disorders in patients with Parkinson’s disease. The aim is to further explore the feasibility of non-invasive brain stimulation in the treatment of dysarthria in Parkinson’s disease, providing references and future directions for clinical practice.
No takes yet. Share an insight, caveat, or question.
Luo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: